Virtu Financial LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$42
+600.0%
53,501
+152.8%
0.00%
+300.0%
Q4 2022$6
-100.0%
21,165
-68.8%
0.00%
-66.7%
Q3 2022$34,000
+161.5%
67,802
+195.6%
0.00%
+200.0%
Q2 2022$13,000
-77.2%
22,935
-54.1%
0.00%
-83.3%
Q4 2021$57,000
-74.7%
49,959
-56.1%
0.01%
-72.7%
Q2 2021$225,000
-31.6%
113,869
-36.4%
0.02%
-4.3%
Q1 2021$329,000
+316.5%
179,030
+1114.5%
0.02%
+187.5%
Q4 2019$79,000
+79.5%
14,741
-18.4%
0.01%
+166.7%
Q3 2019$44,00018,0600.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders